Links
Organizations
Conferences
Info & Opinion
- Applied Clinical Trials
- Bio-IT World
- ClinPsych
- Clinical Trials Today
- Tom Lamb
- George Laszlo
- Pharma Voice
- Ed Silverman
- TJOLS
October 12, 2008
GSK's Checklist for PRO
Patients, In Their Own Words
Highlights from a recent Center for Business Intelligence conference on patient reported outcomes.
Adaptive Logistics
Linking Clinical Trial, Supply Simulation
Cytel and Tourtellotte Consulting join forces to design trials and drug supply needs for adaptive protocols.
Legal Prowess, PR Fumble
Merck’s Deeper Peril
An article in the Harvard Business Review in February 2007 outlines the mistakes of companies that do not engage the media, and offers a prescription for regaining a good public image.
- Home
- Tag
- merck
The most notable nugget from the Center for Business Intelligence’s (CBI) Arlington, Virginia meeting on patient-reported outcome (PRO) research late last month was not so much from the podium, though there was plenty of excellent material there. Some of the…
The math of adaptive trials is hairy. But the appeal is simple. Adaptive trials can reveal the optimal dose in a single trial—not six. They can identify dud drugs early. The approach can require significantly smaller sample sizes and save…
We’ve been as surprised as anyone by the Wall Street Journal’s running baseball-style scorecards showing how many lawsuits Merck has won, lost and tied. It’s notable. Merck is using a starkly different strategy than the one that was popular not…
